142 related articles for article (PubMed ID: 23209540)
21. Synthesis and cytotoxic activity of fluorinated analogues of Goniothalamus lactones. Impact of fluorine on oxidative processes.
Dumitrescu L; Mai Huong DT; Van Hung N; Crousse B; Bonnet-Delpon D
Eur J Med Chem; 2010 Jul; 45(7):3213-8. PubMed ID: 20392543
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
[TBL] [Abstract][Full Text] [Related]
23. Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
Al-Awar RS; Corbett TH; Ray JE; Polin L; Kennedy JH; Wagner MM; Williams DC
Mol Cancer Ther; 2004 Sep; 3(9):1061-7. PubMed ID: 15367700
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
Menon K; Alvarez E; Forler P; Phares V; Amsrud T; Shih C; Al-Awar R; Teicher BA
Cancer Chemother Pharmacol; 2000; 46(2):142-9. PubMed ID: 10972484
[TBL] [Abstract][Full Text] [Related]
25. Asymmetric Syntheses of Potent Antitumor Macrolides Cryptophycin B and Arenastatin A.
Ghosh AK; Bischoff A
European J Org Chem; 2004 May; 2004(10):2131-2141. PubMed ID: 30443158
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological evaluation of fluorinated analogues of salicylihalamide.
Sugimoto Y; Konoki K; Murata M; Matsushita M; Kanazawa H; Oishi T
J Med Chem; 2009 Feb; 52(3):798-806. PubMed ID: 19117395
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of Unit A of Cryptophycin via a [2,3]-Wittig Rearrangement.
Liang J; Hoard DW; Khau VV; Martinelli MJ; Moher ED; Moore RE; Tius MA
J Org Chem; 1999 Mar; 64(5):1459-1463. PubMed ID: 11674204
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
Kumar A; Kumar M; Sharma S; Guru SK; Bhushan S; Shah BA
Eur J Med Chem; 2015 Mar; 93():55-63. PubMed ID: 25647428
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines.
McDaid HM; Bhattacharya SK; Chen XT; He L; Shen HJ; Gutteridge CE; Horwitz SB; Danishefsky SJ
Cancer Chemother Pharmacol; 1999; 44(2):131-7. PubMed ID: 10412947
[TBL] [Abstract][Full Text] [Related]
30. The cryptophycins as potent payloads for antibody drug conjugates.
Verma VA; Pillow TH; DePalatis L; Li G; Phillips GL; Polson AG; Raab HE; Spencer S; Zheng B
Bioorg Med Chem Lett; 2015 Feb; 25(4):864-8. PubMed ID: 25613677
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
[TBL] [Abstract][Full Text] [Related]
32. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
[TBL] [Abstract][Full Text] [Related]
33. Cephalostatin analogues--synthesis and biological activity.
Flessner T; Jautelat R; Scholz U; Winterfeldt E
Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
[TBL] [Abstract][Full Text] [Related]
34. Total Synthesis of Cryptophycins via a Chemoenzymatic Approach.
Salamonczyk GM; Han K; Guo Zw ZW; Sih CJ
J Org Chem; 1996 Oct; 61(20):6893-6900. PubMed ID: 11667584
[TBL] [Abstract][Full Text] [Related]
35. Novel fluorinated acridone derivatives. Part 1: synthesis and evaluation as potential anticancer agents.
Fadeyi OO; Adamson ST; Myles EL; Okoro CO
Bioorg Med Chem Lett; 2008 Jul; 18(14):4172-6. PubMed ID: 18541426
[TBL] [Abstract][Full Text] [Related]
36. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
[TBL] [Abstract][Full Text] [Related]
37. Efficient and versatile stereoselective synthesis of cryptophycins.
Mast CA; Eissler S; Stoncius A; Stammler HG; Neumann B; Sewald N
Chemistry; 2005 Aug; 11(16):4667-77. PubMed ID: 15915529
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
39. The cryptophycins: their synthesis and anticancer activity.
Eggen M; Georg GI
Med Res Rev; 2002 Mar; 22(2):85-101. PubMed ID: 11857635
[TBL] [Abstract][Full Text] [Related]
40. Fluorinated proteins: from design and synthesis to structure and stability.
Marsh EN
Acc Chem Res; 2014 Oct; 47(10):2878-86. PubMed ID: 24883933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
